Prevision Medicine AG

More than 50% of patients with cancer do not respond to the drug given to them. We developed an ex-vivo method that can test 120+ drugs in parallel on a patient's live cancer cells to identify those that are effective for this patient. The test results are then used by oncologists to help them make individual treatment decisions. Several clinical trials have shown that patients treated based on results using our technology had longer overall survival than those treated based on the standard of care.